Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 21 Apr 23 EFFECT Notice of effectiveness
- 20 Apr 23 424B3 Prospectus supplement
-
18 Apr 23 S-4/A Registration of securities issued in business combination transactions (amended)
- 5 Apr 23 S-4 Registration of securities issued in business combination transactions
ADAP similar filings
Filing view
External links
Exhibit 23.2
Consent of Independent Registered Public Accounting Firm
We consent to the use of our reports dated March 6, 2023, with respect to the consolidated financial statements of Adaptimmune Therapeutics Plc, and the effectiveness of internal control over financial reporting incorporated herein by reference and to the reference to our firm under the heading “Experts” in the prospectus.
/s/ KPMG LLP
Reading, United Kingdom
April 18, 2023